Document is current
Any future updates will be listed below
-
Authors
Mokhtar, Sara B. A.
Viljoen, Jessica
van der Kallen, Carla J. H.
Berendschot, Tos T. J. M.
Dagnelie, Pieter C.
Albers, Jeroen D.
Soeterboek, Jens
Scarpa, Fabio
Colonna, Alessia
van der Heide, Frank C. T.
van Greevenbroek, Marleen M. J.
Bosm, Hans
Kroon, Abraham A.
Nuijts, Rudy M. M. A.
Gijs, Marlies
Lakerveld, Jeroen
Malik, Rayaz A.
Webers, Carroll A. B.
Stehouwer, Coen D. A.
Koster, Annemarie
-
Funding
Funding for this research was provided by:
OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (31O.041, 31O.041, 31O.041, 31O.041, 31O.041, 31O.041, 31O.041, 31O.041, 31O.041, 31O.041, 31O.041, 31O.041, 31O.041, 31O.041)
Stichting de Weijerhorst
the Pearl String Initiative Diabetes
the Cardiovascular Center
the School for Cardiovascular Diseases
the School of Mental Health and Neuroscience
the School for Public Health and Primary Care
the School for Nutrition and Translational Research in Metabolism
Stichting Annadal
Health Foundation Limburg
Perimed
Janssen-Cilag
Novo Nordisk
Sanofi-Aventi
GECCO is financially supported by The Netherlands Organisation for Scientific Research (NWO), The Netherlands
- License Information
-
More Information
Article History
Received: 24 April 2024
Accepted: 26 August 2024
First Online: 4 September 2024
Declarations
:
: The Maastricht study was approved by the institutional medical ethical committee (NL31329.068.10) and the Minister of Health, Welfare and Sports of the Netherlands (permit 131088–105234-PG). All participants gave written informed consent.
: Not applicable.
: The authors declare no competing interests.
